Brian Dorsey, VP Product Development at Somaxon Pharmaceuticals, Inc. (SOMX), sold 20,712 shares at $3.06 ($63K) on 2010-02-05, disclosed to the SEC on 2010-02-09.
Scheduled sale ($63k) by VP Product Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| SPRY | SELL | 2024-08-21 | $750K | — | Filing → |
| SPRY | SELL | 2024-08-15 | $390K | — | Filing → |
| APRI | BUY | 2014-12-30 | $11K | — | Filing → |